HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Familial dysalbuminemic hyperthyroxinemia and thyroid hormone autoantibodies: interference in current free thyroid hormone assays.

Abstract
The interference of familial dysalbuminemic hyperthyroxinemia (FDH), antithyroxine (anti-T4) or antitriiodothyronine (anti-T3) antibodies in serum free T4 (FT4) or free T3 (FT3) assays depends on the assay method: two-step immunoextraction, one-step labelled ligand (analogue or derivative tracer) or labelled antibody (solid-phase antigen-linked technique: SPALT) method. For FDH subjects, only FT4 measurements by one two-step method gave reliable results in all cases. However, the overestimation was less marked with new SPALT assays than with previous analogue-based assays. In sera containing anti-T4 antibodies, two-step assays and SPALT assays with a T3-coated solid phase can be considered as reliable for FT4 determination. All other methods including SPALT assays with a T4-coated solid phase may give falsely high results. In sera containing anti-T3 antibodies, SPALT FT4 and FT3 assays with a T3-coated solid phase may give spuriously high values. Anti-T3 antibodies do not interfere in two-step FT3 assays and SPALT FT3 assays with a T2-coated solid phase, but may give high FT3 values as measured by analogue or derivative methods. Moreover, SPALT free thyroid hormone assays may also be subject to interference from antibodies directed towards the assay solid phase.
AuthorsR Sapin, F Gasser, J L Schlienger
JournalHormone research (Horm Res) Vol. 45 Issue 3-5 Pg. 139-41 ( 1996) ISSN: 0301-0163 [Print] Switzerland
PMID8964572 (Publication Type: Journal Article, Review)
Chemical References
  • Autoantibodies
  • Serum Albumin
  • Thyroid Hormones
  • Triiodothyronine
  • Thyroxine
Topics
  • Autoantibodies (analysis)
  • Humans
  • Hyperthyroxinemia (blood)
  • Methods
  • Serum Albumin (analysis)
  • Thyroid Hormones (blood, immunology)
  • Thyroxine (blood, immunology)
  • Triiodothyronine (blood, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: